Aardvark Therapeutics, Inc. Common Stock

AARDUSD

4.76-71.3%1Y · USD

Aardvark Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapeutics that activate innate homeostatic pathways for the treatment of metabolic diseases. The company was incorporated in 2017 and is headquartered in San Diego, California.